Page last updated: 2024-11-08

beta-casomorphin 4

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID173253
MeSH IDM0127151

Synonyms (14)

Synonym
beta-casomorphin 4
(2s)-1-[(2s)-2-[[(2s)-1-[(2s)-2-amino-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoyl]pyrrolidine-2-carboxylic acid
74171-19-0
beta-casomorphin 4 (ox)
tyr-pro-phe-pro
1-(n-(1-l-tyrosyl-l-prolyl)-l-phenylalanyl)-l-proline
l-proline, 1-(n-(1-l-tyrosyl-l-prolyl)-l-phenylalanyl)-
tyrosyl-prolyl-phenylalanyl-proline
DTXSID70225142
l-tyr-pro-phe-pro
beta-casomorphin(1-4)(bovine)
(s)-1-((s)-2-((s)-1-((s)-2-amino-3-(4-hydroxyphenyl)propanoyl)pyrrolidine-2-carboxamido)-3-phenylpropanoyl)pyrrolidine-2-carboxylic acid
l-tyrosyl-l-prolyl-l-phenylalanyl-l-proline
AKOS040746618

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Analysis of the slopes of the dose-response curves seems to suggest that differences between the activity of these opioid peptides in SHR and WAG rats are based on a difference in the density and affinity of the subpopulation of the opioid receptors in these strains of rats."( Analgesic activity of morphiceptin, beta-casomorphin-4, and deltakephalin in normotensive Wistar-Glaxo and spontaneously hypertensive rats.
Członkowski, A; Widy-Tyszkiewicz, E,
)
0.13
" Only beta-CM5 was effective, and the dose-response relationship was graded."( beta-Casomorphin causes hypoalgesia in 10-day-old rats: evidence for central mediation.
Blass, EM; Blom, J, 1996
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (3)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.17

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.17 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.25 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.17)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]